Finance

Lists
ENTA:NASDAQ
Enanta Pharmaceuticals Inc
12,62 $
-1,71%
(-0,22) 1D
2 հոկ, 15:06:21 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTA...
Open
13,20 $
High
13,21 $
Low
12,58 $
Mkt. cap
367,56 մլն
Avg. vol.
268,28 հզր
Volume
296,70 հզր
52-wk high
17,15 $
52-wk low
10,12 $
EPS
-2,41 $
Beta
0,96
Shares outstanding
29,12 մլն
No. of employees
120
Open
13,20 $
High
13,21 $
Low
12,58 $
Mkt. cap
367,56 մլն
Avg. vol.
268,28 հզր
Volume
296,70 հզր
52-wk high
17,15 $
52-wk low
10,12 $
EPS
-2,41 $
Beta
0,96
Shares outstanding
29,12 մլն
No. of employees
120
News stories
From web sources and news partners
About Enanta Pharmaceuticals Inc
CEO-
Employees120
Founded1995
HeadquartersՈւոթերթաուն, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websiteenanta.com
Analyst ratings
Based on 1 analyst giving stock ratings to ENTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ENTA in the last 3 months
Highest
Current 12,62 $
20,00 $ (+58,48%)
Average
20,00 $ (+58,48%)
Lowest
20,00 $ (+58,48%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
20,00 $
+58,5%
09/23/2026
Unknown Analyst
Rodman & Renshaw
Buy
Initiated
20,00 $
+58,5%
03/26/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
19,00 $
+50,6%
03/03/2026
Last report
10 օգս, 2026 թ.
Fiscal period
Q3 2026
EPS / Est. (USD)
-0,67 $ / -0,52 $
-27,86%miss
Revenue / Est. (USD)
14,36 մլն / 16,37 մլն
-12,28%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
15,12 մլն
18,62 մլն
17,16 մլն
14,36 մլն
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
23,81 մլն
20,86 մլն
19,44 մլն
22,13 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,70 մլն
9,01 մլն
9,57 մլն
9,47 մլն
Operating expense
33,51 մլն
29,87 մլն
29,01 մլն
31,60 մլն
Total operating expenses
33,51 մլն
29,87 մլն
29,01 մլն
31,60 մլն
Operating income
-18,39 մլն
-11,25 մլն
-11,85 մլն
-17,24 մլն
Other non operating income
39,00 հզր
-
-
-
EBT including unusual items
-18,67 մլն
-11,91 մլն
-13,08 մլն
-19,46 մլն
EBT excluding unusual items
-19,63 մլն
-11,89 մլն
-13,08 մլն
-19,46 մլն
Income tax expense
32,00 հզր
24,00 հզր
7,00 հզր
36,00 հզր
Effective tax rate
-0,17%
-0,20%
-0,05%
-0,18%
Other operating expenses
-
-
-
-
Net income
-18,70 մլն
-11,94 մլն
-13,09 մլն
-19,50 մլն
Net profit margin
-123,64%
-64,13%
-76,29%
-135,81%
Earnings per share
-0,87
-0,42
-0,45
-0,67
Interest and investment income
1,11 մլն
2,44 մլն
2,08 մլն
1,90 մլն
Interest expense
-2,39 մլն
-3,08 մլն
-3,32 մլն
-4,13 մլն
Net interest expenses
-1,28 մլն
-641,00 հզր
-1,23 մլն
-2,23 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-17,10 մլն
-10,02 մլն
-10,64 մլն
-16,05 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps